Jefferies Financial Group Inc. Relay Therapeutics, Inc. Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$7.5 - $12.07 $807,750 - $1.3 Million	-107,700 Reduced 51.47%	101,563 $842,000
Q4 2023 Feb 13, 2024	SELL	$6.01 - $11.48 $921,609 - $1.76 Million	-153,346 Reduced 42.29%	209,263 $2.3 Million
Q3 2023 Nov 14, 2023	SELL	$8.24 - $12.97 $589,984 - $928,652	-71,600 Reduced 16.49%	362,609 $3.05 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $3.07 Million - $5.61 Million	306,909 Added 241.09%	434,209 $5.45 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $1.91 Million - $2.9 Million	127,300 New	127,300 $2.1 Million

207

159M

100K

26.8K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $393M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.